N-{4-[4-(2,3-dichlorophenyl)piperazin-1-yl]butyl, butenyl and butynyl}arylcarboxamides as novel dopamine D3 receptor antagonists

Bioorganic and Medicinal Chemistry Letters

Volumn 13, Issue 13, 2003, Pages 2179-2183

  Newman, Amy Hauck ^a   Cao, Jianjing ^a   Bennett, Christina J ^a   Robarge, Michael J ^a,c   Freeman, Rebekah A ^b   Luedtke, Robert R ^b  

^a NATIONAL INSTITUTE ON DRUG ABUSE   (United States)

^b UNIVERSITY OF NORTH TEXAS HEALTH SCIENCE CENTER   (United States)

^c CELGENE CORPORATION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMIDE; DOPAMINE 3 RECEPTOR BLOCKING AGENT; LIGAND; N [4 [4 (2,3 DICHLOROPHENYL)PIPERAZIN 1 YL]BUTENYL]CARBOXAMIDE; N [4 [4 (2,3 DICHLOROPHENYL)PIPERAZIN 1 YL]BUTYL]CARBOXAMIDE; N [4 [4 (2,3 DICHLOROPHENYL)PIPERAZIN 1 YL]BUTYNYL]CARBOXAMIDE; NGB 2094; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; DRUG CONFORMATION; DRUG POTENCY; DRUG RECEPTOR BINDING; DRUG SCREENING; DRUG SELECTIVITY; DRUG SYNTHESIS; INSECT CELL; LIPOPHILICITY; NONHUMAN; PROTEIN EXPRESSION; RAT; RECEPTOR AFFINITY; SUBSTITUTION REACTION;

EID: 0038548068     PISSN: 0960894X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0960-894X(03)00389-5     Document Type: Article

References (23)

1. Levant B. Pharm. Rev. 49:1997;231.
2. Joyce J.N. Pharmacol. Ther. 90:2001;231.
3. Le Foll B., Schwartz J.C., Sokoloff P. Eur. J. Psychiatry. 15:2000;140.
4. Richtand N.M., Goldsmith R.J., Nolan J.E., Berger S.P. J. Addictive Dis. 20:2001;19.
5. Pilla M., Perachon S., Sautel F., Garrido F., Mann A., Wermuth C.G., Schwartz J.C., Everitt B.J., Sokoloff P. Nature. 400:1999;371.
6. Beardsley P.M., Sokoloff P., Balster R.L., Schwarz J.-C. Behav. Pharmacol. 12:2001;1.
7. Stemp G., Ashmeade T., Branch C.L., Hadley M.S., Hunter A.J., Johnson C.N., Nash D.J., Thewlis K.M., Vong A.K.K., Austin N.E., Jeffrey P., Avenell K.Y., Boyfield I., Hagan J.J., Middlemiss D.N., Reavill C., Riley G.J., Routledge C., Wood M. J. Med. Chem. 43:2000;1878.
8. Vorel S.R., Ashby C.R., Paul M., Liu X.H., Hayes R., Hagan J.J., Middlemiss D.N., Stemp G., Gardner E.L. J. Neurosci. 22:2002;9595.
9. Robarge M.J., Husbands S.M., Kieltyka A., Brodbeck R., Thurkauf A., Newman A.H. J. Med. Chem. 44:2001;3175.
10. Bettinetti L., Schlotter K., Hubner H., Gmeiner P. J. Med. Chem. 45:2002;4594.
11. Leopoldo M., Berardi F., Colabufo N.A., De Giorgio P., Lacivita E., Perrone R., Tortorella V. J. Med. Chem. 45:2002;5727.
12. Hackling A.E., Stark H. ChemBioChem. 3:2002;946.
13. Luedtke R.R., Freeman R.A., Boundy V.A., Martin M.W., Mach R.H. Synapse. 38:2000;438.
14. Huang Y.S., Luedtke R.R., Freeman R.A., Wu L., Mach R.H. J. Med. Chem. 44:2001;1815.
15. Calculated partition coefficient at physiological pH 7.4; ACD/LogD Suite, Advanced Chemistry Development Inc.: Toronto, Canada.
16. Belliotti T.R., Kesten S.R., Rubin J.R., Wustrow D.J., Georgic L.M., Zoski K.T., Akunne H.C., Wise L.D. Bioorg. Med. Chem. Lett. 18:1997;2403.
17. Austin N.E., Avenell K.Y., Boyfield I., Branch C.L., Hadley M.S., Jeffrey P., Johnson C.N., Macdonald G.J., Nash D.J., Riley G.J., Smith A.B., Stemp G., Thewlis K.M., Vong A.K.K., Wood M. Bioorg. Med. Chem. Lett. 10:2000;2553.
18. Yuan J., Chen X., Brodbeck R., Primus R., Braun J., Wasley J.W.F., Thurkauf A. Bioorg. Med. Chem. Lett. 8:1998;2715.
19. Wood M.D., Boyfield I., Nash D.J., Jewitt F.R., Avenell K.Y., Riley G.J. Eur. J. Pharmacol. 407:2000;47.
20. Wicke K., Garcia-Ladona J. Eur. J. Pharmacol. 424:2001;85.
21. Gong Y., Pauls H.W. Synlett. 2000;829.
22. Agoston G.E., Wu J.H., Izenwasser S., George C., Katz J.L., Kline R.H., Newman A.H. J. Med. Chem. 40:1997;4329.
23. Cheng Y.C., Prusoff W.H. Biochem. Pharmacol. 22:1973;3099.